Biosimilar epoetin alpha is as effective as originator epoetin-alpha plus liposomal iron (Sideral (R)), vitamin B12 and folates in patients with refractory anemia: A retrospective real-life approach

被引：18

作者：

Giordano, Giulio ^{[1
]}

Mondello, Patrizia ^{[3
]}

Tambaro, Rosa ^{[4
]}

Perrotta, Nicola ^{[5
]}

D'Amico, Fabio ^{[8
]}

D'Aveta, Antonietta ^{[1
]}

Berardi, Giuseppe ^{[6
]}

Carabellese, Bruno ^{[2
]}

Patriarca, Andrea ^{[7
]}

Corbi, Grazia Maria ^{[8
]}

Di Marzio, Luigi ^{[2
]}

Licianci, Antonietta ^{[2
]}

Berardi, Donata ^{[9
]}

Di Lullo, Liberato ^{[10
]}

Di Marco, Roberto ^{[8
]}

机构：

[1] Reg Hosp A Cardarelli, Gen Med & Hematol, I-86100 Campobasso, Molise, Italy

[2] Cardarelli Hosp, Serv Dept, I-86100 Campobasso, Molise, Italy

[3] G Martino Univ Hosp, Dept Oncol, I-98100 Messina, Italy

[4] G Pascale Canc Inst, I-80100 Naples, Campania, Italy

[5] Univ G dAnnunzio, Fac Pharmacol, I-66100 Chieti, Italy

[6] Reg Hlth Serv A Cardelli, Family Med, I-86100 Campobasso, Molise, Italy

[7] Publ Hosp, Med & Hematol Unit, I-13900 Biella, Italy

[8] Univ Molise, Sch Med, I-86100 Campobasso, Molise, Italy

[9] Univ Roma La Sapienza, Fac Med, I-00185 Rome, Italy

[10] Reg Hlth Serv A Cardelli, Dept Oncol, I-86100 Campobasso, Molise, Italy

来源：

MOLECULAR AND CLINICAL ONCOLOGY | 2015年 / 3卷 / 04期

关键词：

myelodysplastic syndrome; liposomal iron; hemoglobin; anemia;

D O I：

10.3892/mco.2015.555

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Several biosimilar versions of recombinant human erythropoietin are currently approved for use in Europe, including a biosimilar epoetin-alpha. The aim of this the study was to verify that biosimilar epoetin-alpha is similar in terms of efficacy, safety and cost to originator epoetin-alpha for the treatment of refractory anemia in patients with myelodysplastic syndrome. A total of 92 patients with myelodysplasia and refractory anemia were investigated. The patients received either originator (group A) or biosimilar (group B) epoetin-alpha. In addition, they received liposomal iron (Sideral (R)), calcium levofolinate and vitamin B12. Moreover, the median monthly overall costs were calculated for each group. The results demonstrated that hemoglobin (Hb) levels increased by 1 g/dl after a median time of 5 weeks in group A and 4 weeks in group B. In group A, a Hb level of >12 g/dl was achieved after 12 weeks, while in group B after 10.5 weeks. The median cost of therapy was 1,536 euros/month in group A and 1,354 euros/month in group B. A total of 5 patients required transfusion support in group A and 7 in group B. In conclusion, biosimilar epoetin-alpha appears to be comparable to originator epoetin-alpha in terms of efficacy and safety for the treatment of refractory anemia.

引用

页码：781 / 784

页数：4

共 31 条

[1] Alessandrino EP, 2002, HAEMATOLOGICA, V87, P1286
[2] Anemia of inflammation: the cytokine-hepcidin link
Andrews, NC
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (09) : 1251 - 1253
[3] Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial
Auerbach, M
Ballard, H
Trout, JR
McIlwain, M
Ackerman, A
Bahrain, H
Balan, S
Barker, L
Rana, J
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1301 - 1307
[4] Should intravenous iron be the standard of care in oncology?
Auerbach, Michael
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) : 1579 - 1581
[5] IMPROVEMENT OF ANEMIA BY RECOMBINANT ERYTHROPOIETIN IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND APLASTIC-ANEMIA
BESSHO, M
JINNAI, I
MATSUDA, A
SAITO, M
HIRASHIMA, K
[J]. INTERNATIONAL JOURNAL OF CELL CLONING, 1990, 8 (06): : 445 - 458
[6] Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes
Bowen, D
Culligan, D
Jowitt, S
Kelsey, S
Mufti, G
Oscier, D
Parker, J
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (02) : 187 - 200
[7] Brockmeyer C, 2009, EJHP PRACT, V15, P34
[8] Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia
Cheson, Bruce D.
Greenberg, Peter L.
Bennett, John M.
Lowenberg, Bob
Wijermans, Pierre W.
Nimer, Stephen D.
Pinto, Antonio
Beran, Miloslav
de Witte, Theo M.
Stone, Richard M.
Mittelman, Moshe
Sanz, Guillermo F.
Gore, Steven D.
Schiffer, Charles A.
Kantarjian, Hagop
[J]. BLOOD, 2006, 108 (02) : 419 - 425
[9] Giordano G, 2011, LEUKEMIA RES, V35, pS137, DOI [10.1016/S0145-2126(11)70343-5, DOI 10.1016/S0145-2126(11)70343-5]
[10] Greenberg P L, 1999, Forum (Genova), V9, P17

← 1 2 3 4 →